PINX1 and ovarian cancer: Previous studies have shown that reduced expression of PinX1 is implicated in various human cancers, including breast cancer [21, 22], ovarian cancer [19, 20], gastric cancer [16], and liver cancer [31], suggesting that PinX1 may function as a tumour suppressor in multiple human cancers.